vs

Side-by-side financial comparison of Nomad Foods Ltd (NOMD) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Nomad Foods Ltd is the larger business by last-quarter revenue ($834.9M vs $568.5M, roughly 1.5× Real Brokerage Inc). On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs -2.6%). Nomad Foods Ltd produced more free cash flow last quarter ($272.4M vs $8.4M).

Nomad Foods is the largest frozen food company in Europe, whose popular brands include Birds Eye, Ledo, Iglo, Findus, and Frikom. The company manufactures, sells and distributes a range of frozen food products across 22 European markets, with its headquarters in the United Kingdom. The most popular products in Nomad Foods’ portfolio include fish fingers, creamed spinach, peas and chicken. Nomad Foods is listed on the New York Stock Exchange trading under the ticker “NOMD”.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

NOMD vs REAX — Head-to-Head

Bigger by revenue
NOMD
NOMD
1.5× larger
NOMD
$834.9M
$568.5M
REAX
Growing faster (revenue YoY)
REAX
REAX
+55.2% gap
REAX
52.6%
-2.6%
NOMD
More free cash flow
NOMD
NOMD
$264.0M more FCF
NOMD
$272.4M
$8.4M
REAX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
NOMD
NOMD
REAX
REAX
Revenue
$834.9M
$568.5M
Net Profit
$-447.0K
Gross Margin
25.6%
7.9%
Operating Margin
9.1%
-0.1%
Net Margin
-0.1%
Revenue YoY
-2.6%
52.6%
Net Profit YoY
82.7%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NOMD
NOMD
REAX
REAX
Q4 25
$834.9M
Q3 25
$568.5M
Q2 25
$540.7M
Q1 25
$354.0M
Q4 24
$856.9M
Q3 24
$372.5M
Q1 24
$200.7M
Q4 23
$821.7M
Net Profit
NOMD
NOMD
REAX
REAX
Q4 25
Q3 25
$-447.0K
Q2 25
$1.5M
Q1 25
$-5.0M
Q4 24
$55.5M
Q3 24
$-2.6M
Q1 24
$-16.1M
Q4 23
$26.7M
Gross Margin
NOMD
NOMD
REAX
REAX
Q4 25
25.6%
Q3 25
7.9%
Q2 25
8.9%
Q1 25
9.6%
Q4 24
28.5%
Q3 24
8.6%
Q1 24
10.3%
Q4 23
27.3%
Operating Margin
NOMD
NOMD
REAX
REAX
Q4 25
9.1%
Q3 25
-0.1%
Q2 25
0.3%
Q1 25
-1.5%
Q4 24
11.5%
Q3 24
-0.7%
Q1 24
-7.8%
Q4 23
8.8%
Net Margin
NOMD
NOMD
REAX
REAX
Q4 25
Q3 25
-0.1%
Q2 25
0.3%
Q1 25
-1.4%
Q4 24
6.5%
Q3 24
-0.7%
Q1 24
-8.0%
Q4 23
3.2%
EPS (diluted)
NOMD
NOMD
REAX
REAX
Q4 25
Q3 25
$0.00
Q2 25
$0.01
Q1 25
$-0.02
Q4 24
Q3 24
$-0.01
Q1 24
$-0.09
Q4 23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NOMD
NOMD
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$38.7M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$2.7B
$53.6M
Total Assets
$6.8B
$145.2M
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NOMD
NOMD
REAX
REAX
Q4 25
Q3 25
$38.7M
Q2 25
$49.7M
Q1 25
$24.7M
Q4 24
Q3 24
$22.6M
Q1 24
$20.1M
Q4 23
Total Debt
NOMD
NOMD
REAX
REAX
Q4 25
$2.5B
Q3 25
Q2 25
Q1 25
Q4 24
$2.4B
Q3 24
Q1 24
Q4 23
$2.3B
Stockholders' Equity
NOMD
NOMD
REAX
REAX
Q4 25
$2.7B
Q3 25
$53.6M
Q2 25
$49.2M
Q1 25
$32.8M
Q4 24
$2.9B
Q3 24
$29.8M
Q1 24
$25.6M
Q4 23
$2.8B
Total Assets
NOMD
NOMD
REAX
REAX
Q4 25
$6.8B
Q3 25
$145.2M
Q2 25
$149.4M
Q1 25
$100.5M
Q4 24
$6.9B
Q3 24
$102.5M
Q1 24
Q4 23
$6.9B
Debt / Equity
NOMD
NOMD
REAX
REAX
Q4 25
0.92×
Q3 25
Q2 25
Q1 25
Q4 24
0.82×
Q3 24
Q1 24
Q4 23
0.82×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NOMD
NOMD
REAX
REAX
Operating Cash FlowLast quarter
$357.2M
$8.8M
Free Cash FlowOCF − Capex
$272.4M
$8.4M
FCF MarginFCF / Revenue
32.6%
1.5%
Capex IntensityCapex / Revenue
10.2%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.3B
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NOMD
NOMD
REAX
REAX
Q4 25
$357.2M
Q3 25
$8.8M
Q2 25
$41.0M
Q1 25
$15.9M
Q4 24
$470.2M
Q3 24
$7.2M
Q1 24
$21.5M
Q4 23
$465.3M
Free Cash Flow
NOMD
NOMD
REAX
REAX
Q4 25
$272.4M
Q3 25
$8.4M
Q2 25
$40.8M
Q1 25
$15.7M
Q4 24
$383.5M
Q3 24
$6.8M
Q1 24
$21.4M
Q4 23
$376.3M
FCF Margin
NOMD
NOMD
REAX
REAX
Q4 25
32.6%
Q3 25
1.5%
Q2 25
7.5%
Q1 25
4.4%
Q4 24
44.8%
Q3 24
1.8%
Q1 24
10.7%
Q4 23
45.8%
Capex Intensity
NOMD
NOMD
REAX
REAX
Q4 25
10.2%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
10.1%
Q3 24
0.1%
Q1 24
0.0%
Q4 23
10.8%
Cash Conversion
NOMD
NOMD
REAX
REAX
Q4 25
Q3 25
Q2 25
27.13×
Q1 25
Q4 24
8.47×
Q3 24
Q1 24
Q4 23
17.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons